Laurion Capital Management LP Aeglea Bio Therapeutics, Inc. Transaction History

Laurion Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.5 - $2.66 $787,819 - $4.19 Million	-1,575,638 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.87 - $4.77 $233,750 - $596,250	125,000 Added 8.62%	1,575,638 $3.62 Million
Q4 2021 Feb 14, 2022	BUY	$3.5 - $8.42 $2.95 Million - $7.11 Million	844,000 Added 139.13%	1,450,638 $6.89 Million
Q3 2021 Nov 15, 2021	BUY	$6.03 - $7.95 $3.66 Million - $4.82 Million	606,638 New	606,638 $4.82 Million

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.